These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8648551)

  • 1. Antibiotic-resistant pneumococci.
    Friedland IR
    J Pediatr; 1996 Jun; 128(6):862-3. PubMed ID: 8648551
    [No Abstract]   [Full Text] [Related]  

  • 2. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
    Chesney PJ; Davis Y; English BK; Wang WC
    Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistant pneumococcal meningitis revealing sickle cell anemia: efficacy of cefotaxime-vancomycin combination].
    Agbo P; Chalvon-Demersay A; Hacquard B; Carnot JF; Mariani P; Cayroche P
    Arch Pediatr; 1995 Aug; 2(8):799-800. PubMed ID: 7550848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
    Martín Fontelos P; Barreiro Casal G; Villota Arrieta J; Pérez Jurado ML; García López M; Mellado Peña MJ; Cilleruelo Ortega MJ
    An Esp Pediatr; 1996 Apr; 44(4):395-6. PubMed ID: 8796948
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of antibiotic resistance on chemotherapy for pneumococcal infections.
    Pallares R; Viladrich PF; Liñares J; Cabellos C; Gudiol F
    Microb Drug Resist; 1998; 4(4):339-47. PubMed ID: 9988053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections.
    Pallares R; Capdevila O; Liñares J; Grau I; Onaga H; Tubau F; Schulze MH; Hohl P; Gudiol F
    Am J Med; 2002 Aug; 113(2):120-6. PubMed ID: 12133750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.
    Pacheco TR; Cooper CK; Hardy DJ; Betts RF; Bonnez W
    Am J Med; 1997 Mar; 102(3):303-5. PubMed ID: 9217602
    [No Abstract]   [Full Text] [Related]  

  • 9. The growing threat of antibiotic-resistant Streptococcus pneumoniae.
    Lonks JR; Medeiros AA
    Med Clin North Am; 1995 May; 79(3):523-35. PubMed ID: 7752726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002.
    Kaplan SL; Mason EO
    Pediatr Ann; 2002 Apr; 31(4):250-60. PubMed ID: 11966248
    [No Abstract]   [Full Text] [Related]  

  • 11. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.
    Obert CA; Miller ML; Montgomery J; Adamkiewicz T; Tuomanen EI
    Antimicrob Agents Chemother; 2007 Jan; 51(1):386-9. PubMed ID: 17060526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain.
    Vandecasteele SJ; Verhaegen J; Colaert J; Van Caster A; Devlieger H
    Eur J Clin Microbiol Infect Dis; 2001 Oct; 20(10):751-2. PubMed ID: 11757981
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
    John CC
    Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
    Olivier C; Cohen R; Begué P; Floret D
    Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
    [No Abstract]   [Full Text] [Related]  

  • 17. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
    Hicks LA; Chien YW; Taylor TH; Haber M; Klugman KP;
    Clin Infect Dis; 2011 Oct; 53(7):631-9. PubMed ID: 21890767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem.
    Klugman KP; Feldman C
    Drugs; 1999 Jul; 58(1):1-4. PubMed ID: 10439925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalosporin-resistant pneumococci and sickle cell disease.
    Miller ML; Obert CA; Gao G; Daw NC; Flynn P; Tuomanen E
    Emerg Infect Dis; 2005 Aug; 11(8):1192-6. PubMed ID: 16102306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Streptococcus pneumoiae meningitis in infants].
    Bingen E; Cohen R; Bourrillon A
    Arch Pediatr; 1994 Aug; 1(8):756-8. PubMed ID: 7654271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.